Erratum for McCollister et al., Whole-Genome Sequencing Identifies In Vivo Acquisition of a bla_CTX-M-27-Carrying IncFII Transmissible Plasmid as the Cause of Ceftriaxone Treatment Failure for an Invasive Salmonella enterica Serovar Typhimurium Infection

ERRATUM

Volume 60, no. 12, p. 7224–7235, 2016. Due to a typesetting error, several symbols in Table 1 are incorrect. The correct table appears below.

TABLE 1.

Microscan MIC reports for susceptible and resistant Salmonella and E. coli strains

Agenta	Microscan MIC (μg/ml)b
	Salmonella ST882S (susceptible)	Salmonella ST931R (resistant)	E. coli ER1821R (susceptible)	Transconjugant E. coli ER1821R (resistant)
AMP	≤8	>16	≤8	>16
AMP-SUL	≤8/4	16/8	≤8/4	16/8
AMX-CLA	≤8/4	≤8/4	≤8/4	≤8/4
Cefazolin	≤8	>16	≤8	>16
Ceftriaxone	≤8	>32	≤8	>32
Cefotaxime	≤2	>32	≤2	>32
Cefotaxime-CLA	≤0.5	≤0.5	≤0.5	≤0.5
Ceftazidime	≤1	>16	≤1	>16
Ceftazidime-CLA	≤0.5	≤0.5	≤0.5	≤0.5
Cefepime	≤4	>16	≤4	>16
PIP-TZB	≤16	≤16	≤16	≤16
Ertapenem	≤2	≤2	≤2	≤2
Gentamicin	≤4	≤4	≤4	≤4
Levofloxacin	≤2	≤2	≤2	≤2
Tetracycline	≤4	≤4	≤4	≤4
SXT	≤2/38	≤2/38	≤2/38	≤2/38

^aAMP, ampicillin; CLA, clavulanic acid; AMX, amoxicillin; SUL, sulbactam; PIP-TZB, piperacillin-tazobactam; SXT, trimethoprim-sulfamethoxazole.

^bBoldface indicates MIC levels that were reported as resistant, except for AMP-SUL, which was reported as intermediate.